Back to results
US 6,294,377 B1Granted
Adenoviral vectors of canine origin
AssigneeRhone-Poulenc Rorer S.A.
InventorsHedi Haddada, Bernard Klonjkowski, Michel Perricaudet, Emmanuelle Vigne
Life of this patent
Estimating the term…
Abstract
The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.
Claims6
A recombinant canine CAV-2 adenovirus, comprising at least one inserted human gene and sequences permitting expression of the inserted gene in a human cell in which the recombinant adenovirus is infectious.
Dependencies are inferred from the claim text.